John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 24,999 shares at $17.99 ($450K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Scheduled sale ($450k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |
| ALDR | SELL | 2018-06-05 | $446K | — | Filing → |